1
Interventional Therapy Sequential With the Fourth-generation CAR-T Targeting Nectin4/FAP for Malignant Solid Tumors
Condition(s):Nectin4-positive Advanced Malignant Solid TumorLast Updated:April 30, 2019Recruiting
Solid Tumor: 10758 Clinical Trials, Page 1 of 1076
Hide Studies Not Open or Pending
2
Advanced Refractory Solid Tumors With TP53 Mutations Register Study
Condition(s):Solid Tumor, AdultLast Updated:August 20, 2019Enrolling by invitation
3
Genetic Investigation of Solid Tumors Cohort
Condition(s):Prostate Cancer; Colon CancerLast Updated:June 12, 2014Completed
4
Dose-escalation Study of APG-1387 and Toripalimab in Solid Tumors
Condition(s):Advanced Solid TumorLast Updated:May 21, 2020Recruiting
5
TCR-T Cell for Immunotherapy of Lung Cancer and Other Solid Tumors
Condition(s):Nonsmall Cell Lung Cancer; Solid Tumor, AdultLast Updated:June 25, 2019Recruiting
6
Anlotinib in Advanced Solid Tumors With FGFR Alteration
Condition(s):Advanced Solid TumorLast Updated:April 29, 2019Recruiting
7
Study of FCN-437c in Patients With Advanced Solid Tumors
Condition(s):Solid Tumor, AdultLast Updated:May 7, 2020Recruiting
8
CTLA-4 and PD-1 Antibodies Expressing Mesothelin-CAR-T Cells for Mesothelin Positive Advanced Solid Tumor
Condition(s):Advanced Solid TumorLast Updated:June 9, 2017Unknown status
9
CTLA-4 and PD-1 Antibodies Expressing MUC1-CAR-T Cells for MUC1 Positive Advanced Solid Tumor
Condition(s):Advanced Solid TumorLast Updated:June 7, 2017Unknown status
10
MASCT-I Treatment for Advanced Solid Tumor
Condition(s):Solid TumorsLast Updated:August 11, 2016Unknown status